Pediatrics

In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy.

Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.

Identifying high-risk patients with unstable HbA1c levels from childhood to adolescence can have significant outcomes. 

Is there an ideal approach to screen and diagnose children and adolescents for prediabetes and diabetes?

Investigation into plasma glucose and HbA1c before a diagnosis of type 1 diabetes in children.

When metformin therapy fails in youth, alternatives are limited to human insulin and liraglutide.

Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?

A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children. 

Pediatric patients with T2D have accelerated onset of hypertension, dyslipidemia, kidney disease, nerve disease, and diabetic retinopathy.

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.